Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (387)	8/28/2001 4:21:41 PM
From: Jibacoa	Respond to of 1005

<<With abstracts out, what, maybe 3 weeks before?>> The abstracts selected to be presented at Scientific Sessions will be published in a supplement to the October issue of Circulation.( I don't know how long before the conference that will be.<g>) I have to check with one of my sons that does invasive Cardiology if he is planning on attending the meeting at Anaheim. RAGL Bernard

To: keokalani'nui who wrote (387)	8/28/2001 11:12:31 PM
From: Biomaven	Read Replies (1) \| Respond to of 1005

Wilder, <AGIX> But I'm betting that they won't meet the formal end point, so maybe the time to buy them is if they announce at the meeting that they didn't hit it. (Although as I've said before, the trial results actually looked pretty good to me, endpoint or no). I'm out of PTIE, by the way, with a very small profit. I should really emphasize to all that my DD level on most of these Blue stocks is fairly minimal - I'm not buying that much of them and so I'm very much not talking Rick or Miljenko level scrutiny here. Basically I'm prepared to buy a little of any biotech that looks cheap, interesting and where I have a good gut feel. Peter